Levamisole
Levamisole, sold under the brand name Ergamisol among others, is a medication used to treat parasitic worm infections, specifically ascariasis and hookworm infections. It is taken by mouth.
| Clinical data | |
|---|---|
| Trade names | Decaris, Ergamisol |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a697011 |
| License data |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Liver |
| Elimination half-life | 3–4 hours |
| Excretion | Urine (70%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.035.290 |
| Chemical and physical data | |
| Formula | C11H12N2S |
| Molar mass | 204.29 g·mol−1 |
| 3D model (JSmol) | |
| Density | 1.31 g/cm3 |
| Melting point | 60 °C (140 °F) |
| Solubility in water | hydrochloride: 210 mg/mL (20 °C) |
| |
| |
| (what is this?) (verify) | |
Side effects may include abdominal pain, vomiting, headache, and dizziness. Use is not recommended during breastfeeding or the third trimester of pregnancy. Serious side effects may include an increased risk of infection. It belongs to the anthelmintic class of medications.
Levamisole was invented in 1966 in Belgium by Janssen Pharmaceuticals. It is on the World Health Organization's List of Essential Medicines. Levamisole is also used as a dewormer for cattle.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.